Roche Holding AG

Johnson & Johnson stock rises Thursday, still underperforms market

4:32 p.m. April 15, 2021

- MarketWatch Automation

Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains

4:32 p.m. April 14, 2021

- MarketWatch Automation

Johnson & Johnson stock falls Tuesday, underperforms market

4:32 p.m. April 13, 2021

- MarketWatch Automation

Johnson & Johnson stock outperforms competitors on strong trading day

4:32 p.m. April 12, 2021

- MarketWatch Automation

Johnson & Johnson stock underperforms Friday when compared to competitors

4:32 p.m. April 9, 2021

- MarketWatch Automation

Johnson & Johnson stock falls Thursday, underperforms market

4:32 p.m. April 8, 2021

- MarketWatch Automation

Johnson & Johnson stock rises Wednesday, still underperforms market

4:32 p.m. April 7, 2021

- MarketWatch Automation

Johnson & Johnson stock falls Tuesday, still outperforms market

4:32 p.m. April 6, 2021

- MarketWatch Automation

Johnson & Johnson stock rises Monday, still underperforms market

4:32 p.m. April 5, 2021

- MarketWatch Automation

Johnson & Johnson stock underperforms Thursday when compared to competitors

4:33 p.m. April 1, 2021

- MarketWatch Automation

Johnson & Johnson stock underperforms Wednesday when compared to competitors

4:32 p.m. March 31, 2021

- MarketWatch Automation

Johnson & Johnson stock falls Tuesday, underperforms market

4:32 p.m. March 30, 2021

- MarketWatch Automation

Johnson & Johnson stock rises Monday, outperforms market

4:33 p.m. March 29, 2021

- MarketWatch Automation

It’s a ‘question of time’ before another virus jumps from animal to human, says co-inventor of flu treatment Tamiflu. Preventative therapies are needed.

9:26 a.m. March 27, 2021

- Jaimy Lee

Johnson & Johnson stock outperforms market on strong trading day

4:32 p.m. March 26, 2021

- MarketWatch Automation

Johnson & Johnson stock rises Thursday, still underperforms market

4:32 p.m. March 25, 2021

- MarketWatch Automation

Vaccines are here. That’s no reason to call off the hunt for effective COVID-19 treatments.

8:01 a.m. March 25, 2021

- Jaimy Lee

Johnson & Johnson stock outperforms competitors on strong trading day

4:33 p.m. March 24, 2021

- MarketWatch Automation

Ionis shares tumble 19% after Roche halts Phase 3 study for rare-disease drug

3:02 p.m. March 24, 2021

- Jaimy Lee

Fauci insists that AstraZeneca’s COVID-19 vaccine candidate is ‘good’ after issue with information in company’s press release

1:29 p.m. March 24, 2021

- Jaimy Lee

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition

Bristol-Myers Reports Higher Sales, Earnings

7:31 a.m. April 28, 2015

- The Wall Street Journal Interactive Edition

Swiss Companies Battle Strong Franc

11:52 a.m. March 2, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

4:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Roche Gets FDA Priority Review for Cancer Treatment

2:34 a.m. March 20, 2015

- The Wall Street Journal Interactive Edition

Roche Sees Profit, Sales Increasing

4:46 a.m. Jan. 28, 2015

- The Wall Street Journal Interactive Edition

Young Drive an Urban Rebound

12:50 a.m. Jan. 3, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

8:16 p.m. Dec. 29, 2014

- The Wall Street Journal Interactive Edition

Roche Wins Approval for Ebola Test

10:44 a.m. Dec. 29, 2014

- The Wall Street Journal Interactive Edition

Roche Hit by Failure of Cancer Drug Trial

12:55 p.m. Dec. 19, 2014

- The Wall Street Journal Interactive Edition

France Told To Do More for Investors

11:24 a.m. Dec. 17, 2014

- The Wall Street Journal Interactive Edition

Roche’s Genentech Seeks Approval for Skin Cancer Drug

3:12 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

1:30 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Business Briefs: News Digest

8:47 p.m. Dec. 14, 2014

- The Wall Street Journal Interactive Edition

Roche Names New Genentech R&D Chief

6:53 a.m. Dec. 12, 2014

- The Wall Street Journal Interactive Edition

Merck Drug Shrank Tumors in Some Breast Cancer Patients

9:30 a.m. Dec. 10, 2014

- The Wall Street Journal Interactive Edition

Cancer’s Super-Survivors

4:58 p.m. Jan. 8, 2015

- The Wall Street Journal Interactive Edition

Bristol-Myers Drug Shows Promise for Skin-Cancer Patients

3:31 a.m. Dec. 15, 2014

- The Wall Street Journal Interactive Edition

Roche Holding AG May Submit Ebola Test For Emergency Use Approvals

2:24 p.m. Oct. 16, 2014

- The Wall Street Journal Interactive Edition

Roche Boosted by Cancer Drugs

5:26 a.m. Oct. 16, 2014

- The Wall Street Journal Interactive Edition